Considering the fact that sleep apnoea itself favours the development of high blood pressure and is considered by some as its most common secondary cause, OSA additive or hyperadditive effect on PAI-1 levels may significantly increase the risk. The gene discussed is SERPINE1; the disease is sleep apnea syndrome.